跳轉至內容
Merck
  • Effect of timing of joint application of hydroquinone and dicyandiamide on nitrous oxide emission from irrigated lowland rice paddy field.

Effect of timing of joint application of hydroquinone and dicyandiamide on nitrous oxide emission from irrigated lowland rice paddy field.

Chemosphere (2009-03-10)
Xianglan Li, Guangbin Zhang, Hua Xu, Zucong Cai, Kazuyuki Yagi
摘要

A field experiment was conducted to study the effect of timing of joint application of urease inhibitor hydroquinone (HQ) and nitrification inhibitor dicyandiamide (DCD) on N(2)O emission from irrigated lowland rice paddy field. Four treatments including Treatment CK (the control with urea alone), HQ/DCD-1 (application of HQ and DCD together with fertilizer before transplanting), HQ/DCD-2 (HQ and DCD with fertilizer at tillering stage) and HQ/DCD-3 (HQ and DCD with fertilizer at panicle initiation stage) were designed and implemented separately during rice growth period. Seasonal peaks of N(2)O flux occurred during midseason drainage and significant negative correlation between N(2)O flux and water layer depth was observed (r=-0.69 to -0.75, P<0.01). Mean N(2)O flux was the highest in the control with urea alone, while joint addition of HQ and DCD with urea lowered mean N(2)O flux considerably (P<0.05). Total N(2)O emission during rice growth season in Treatment CK, HQ/DCD-1, HQ/DCD-2 and HQ/DCD-3 was 3.90, 2.98, 1.73 and 3.23kgN(2)O-N ha(-1), respectively. Application of HQ and DCD together with basal fertilizer, tillering fertilizer and panicle initiation fertilizer decreased the total N(2)O emission by 24%, 56% and 17%, respectively, while increased grain yield by 10%, 18% and 6%, respectively. Effect of application of inhibitors on N(2)O emission during the continuous period from incorporation of HQ and DCD to rice harvest was also studied, where results indicating that the highest inhibiting efficiency of inhibitors on N(2)O emission was recorded when HQ and DCD applied with fertilizer at tillering stage.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
双氰胺, 99%
Supelco
氰基胍, pharmaceutical impurity standard, ≥95.0% (HPLC)